Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer

Abstract

In the selected high-recurrence risk PTC group, most patients had more than one genetic alteration. However, these known alterations could not entirely account for clinicopathological features of high-recurrence risk PTC.